{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:00:51Z","timestamp":1784289651676,"version":"3.55.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04052-x","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:17:20Z","timestamp":1765189040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting asymmetric division in cancer stem cells: implications for relapse and resistance"],"prefix":"10.1186","volume":"25","author":[{"given":"Mona","family":"Latifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"4052_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13287-024-03783-4","volume":"15","author":"F Sani","year":"2024","unstructured":"Sani F, Shojaei S, Tabatabaei SA, Khorraminejad-Shirazi M, Latifi M, Sani M, Azarpira N. CAR-T cell-derived exosomes: a new perspective for cancer therapy. Stem Cell Res Ther. 2024;15:174. https:\/\/doi.org\/10.1186\/s13287-024-03783-4.","journal-title":"Stem Cell Res Ther"},{"key":"4052_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, Zhai Z, Tanzhu G, Yang J, Zhou R. Cancer stem cells: advances in knowledge and implications for cancer therapy. Sig Transduct Target Ther. 2024;9:170. https:\/\/doi.org\/10.1038\/s41392-024-01851-y.","journal-title":"Sig Transduct Target Ther"},{"key":"4052_CR3","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/mog2.70009","volume":"4","author":"Y Tan","year":"2025","unstructured":"Tan Y, Qin S, Zhang Z, Liu Y, Zhou L, Li B, Nice EC, Zhang Y, Jing J. Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies. MedComm \u2013 Oncol. 2025;4:e70009. https:\/\/doi.org\/10.1002\/mog2.70009.","journal-title":"MedComm \u2013 Oncol"},{"key":"4052_CR4","doi-asserted-by":"publisher","first-page":"938685","DOI":"10.3389\/fcell.2022.938685","volume":"10","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang YY, Zhang H, Yang J, Chen Y, Lu H. Asymmetric cell division and tumor heterogeneity. Front Cell Dev Biol. 2022;10:938685. https:\/\/doi.org\/10.3389\/fcell.2022.938685.","journal-title":"Front Cell Dev Biol"},{"key":"4052_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13619-024-00188-9","volume":"13","author":"S Chao","year":"2024","unstructured":"Chao S, Yan H, Bu P. Asymmetric division of stem cells and its cancer relevance. Cell Regen. 2024;13:5. https:\/\/doi.org\/10.1186\/s13619-024-00188-9.","journal-title":"Cell Regen"},{"key":"4052_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/gtc.13172","volume":"29","author":"S Bolkent","year":"2024","unstructured":"Bolkent S. Cellular and molecular mechanisms of asymmetric stem cell division in tissue homeostasis. Genes Cells. 2024;29:1099\u2013110. https:\/\/doi.org\/10.1111\/gtc.13172.","journal-title":"Genes Cells"},{"key":"4052_CR7","doi-asserted-by":"publisher","first-page":"jcs261400","DOI":"10.1242\/jcs.261400","volume":"137","author":"JH Buss","year":"2024","unstructured":"Buss JH, Begnini KR, Lenz G. The contribution of asymmetric cell division to phenotypic heterogeneity in cancer. J Cell Sci. 2024;137:jcs261400. https:\/\/doi.org\/10.1242\/jcs.261400.","journal-title":"J Cell Sci"},{"key":"4052_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13008-021-00073-w","volume":"16","author":"SN Chhabra","year":"2021","unstructured":"Chhabra SN, Booth BW. Asymmetric cell division of mammary stem cells. Cell Div. 2021;16:5. https:\/\/doi.org\/10.1186\/s13008-021-00073-w.","journal-title":"Cell Div"},{"key":"4052_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s12015-023-10523-3","volume":"19","author":"P Samanta","year":"2023","unstructured":"Samanta P, Bhowmik A, Biswas S, Sarkar R, Ghosh R, Pakhira S, Mondal M, Sen S, Saha P, Hajra S. Therapeutic effectiveness of anticancer agents targeting different signaling molecules involved in asymmetric division of cancer stem cell. Stem Cell Rev Rep. 2023;19:1283\u2013306. https:\/\/doi.org\/10.1007\/s12015-023-10523-3.","journal-title":"Stem Cell Rev Rep"},{"key":"4052_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.stem.2022.12.008","volume":"30","author":"D Castillo-Azofeifa","year":"2023","unstructured":"Castillo-Azofeifa D, Wald T, Reyes EA, Gallagher A, Schanin J, Vlachos S, Lamarche-Vane N, Bomidi C, Blutt S, Estes MK, Nystul T, Klein OD. A DLG1-ARHGAP31-CDC42 axis is essential for the intestinal stem cell response to fluctuating niche Wnt signaling. Cell Stem Cell. 2023;30:188\u2013e2066. https:\/\/doi.org\/10.1016\/j.stem.2022.12.008.","journal-title":"Cell Stem Cell"},{"key":"4052_CR11","doi-asserted-by":"publisher","first-page":"113823","DOI":"10.1016\/j.celrep.2024.113823","volume":"43","author":"M Connell","year":"2024","unstructured":"Connell M, Xie Y, Deng X, Chen R, Zhu S. Kin17 regulates proper cortical localization of Miranda in drosophila neuroblasts by regulating Flfl expression. Cell Rep. 2024;43:113823. https:\/\/doi.org\/10.1016\/j.celrep.2024.113823.","journal-title":"Cell Rep"},{"key":"4052_CR12","doi-asserted-by":"publisher","first-page":"jcs261789","DOI":"10.1242\/jcs.261789","volume":"137","author":"RR Penkert","year":"2024","unstructured":"Penkert RR, LaFoya B, Moholt-Siebert L, Vargas E, Welch SE, Prehoda KE. The Drosophila neuroblast Polarity cycle at a glance. J Cell Sci. 2024;137:jcs261789. https:\/\/doi.org\/10.1242\/jcs.261789.","journal-title":"J Cell Sci"},{"key":"4052_CR13","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41467-020-16135-6","volume":"11","author":"Z Liu","year":"2020","unstructured":"Liu Z, Yang Y, Gu A, Xu J, Mao Y, Lu H, Hu W, Lei Q-Y, Li Z, Zhang M, Cai Y, Wen W. Par complex cluster formation mediated by phase separation. Nat Commun. 2020;11:2266. https:\/\/doi.org\/10.1038\/s41467-020-16135-6.","journal-title":"Nat Commun"},{"key":"4052_CR14","doi-asserted-by":"publisher","first-page":"e56074","DOI":"10.15252\/embr.202256074","volume":"24","author":"KE Neville","year":"2023","unstructured":"Neville KE, Finegan TM, Lowe N, Bellomio PM, Na D, Bergstralh DT. The Drosophila mitotic spindle orientation machinery requires activation, not just localization. EMBO Rep. 2023;24:e56074. https:\/\/doi.org\/10.15252\/embr.202256074.","journal-title":"EMBO Rep"},{"key":"4052_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-022-02904-1","volume":"13","author":"F Ju","year":"2022","unstructured":"Ju F, Atyah MM, Horstmann N, Gul S, Vago R, Bruns CJ, Zhao Y, Dong Q-Z, Ren N. Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Res Ther. 2022;13:233. https:\/\/doi.org\/10.1186\/s13287-022-02904-1.","journal-title":"Stem Cell Res Ther"},{"key":"4052_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/JCMA.0000000000000186","volume":"82","author":"K-F Hung","year":"2019","unstructured":"Hung K-F, Yang T, Kao S-Y. Cancer stem cell theory: are we moving past the mist? J Chin Med Association. 2019;82:814\u20138. https:\/\/doi.org\/10.1097\/JCMA.0000000000000186.","journal-title":"J Chin Med Association"},{"key":"4052_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther. 2020;5:228. https:\/\/doi.org\/10.1038\/s41392-020-00313-5.","journal-title":"Signal Transduct Target Ther"},{"key":"4052_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.stem.2020.09.011","volume":"27","author":"E Fuchs","year":"2020","unstructured":"Fuchs E, Blau HM. Tissue stem cells: architects of their niches. Cell Stem Cell. 2020;27:532\u201356. https:\/\/doi.org\/10.1016\/j.stem.2020.09.011.","journal-title":"Cell Stem Cell"},{"key":"4052_CR19","doi-asserted-by":"publisher","first-page":"e202308069","DOI":"10.1083\/jcb.202308069","volume":"223","author":"F Peglion","year":"2024","unstructured":"Peglion F, Etienne-Manneville S. Cell Polarity changes in cancer initiation and progression. J Cell Biol. 2024;223:e202308069. https:\/\/doi.org\/10.1083\/jcb.202308069.","journal-title":"J Cell Biol"},{"key":"4052_CR20","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1158\/0008-5472.CAN-10-4269","volume":"71","author":"TS Zhu","year":"2011","unstructured":"Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, He X, Hervey-Jumper SL, Heth JA, Muraszko KM, DiMeco F, Vescovi AL, Fan X. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture Self-Renewal of cancer stem-Like cells. Cancer Res. 2011;71:6061\u201372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4269.","journal-title":"Cancer Res"},{"key":"4052_CR21","doi-asserted-by":"crossref","unstructured":"Petritsch C, Shen X. Asymmetric Division of Cancer Stem Cells. In: Cancer Stem Cells. pp. 285\u2013315. Elsevier (2016).","DOI":"10.1016\/B978-0-12-803892-5.00011-5"},{"key":"4052_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12935-023-02992-w","volume":"23","author":"S Safaei","year":"2023","unstructured":"Safaei S, Sajed R, Shariftabrizi A, Dorafshan S, Saeednejad Zanjani L, Dehghan Manshadi M, Madjd Z, Ghods R. Tumor matrix stiffness provides fertile soil for cancer stem cells. Cancer Cell Int. 2023;23:143. https:\/\/doi.org\/10.1186\/s12935-023-02992-w.","journal-title":"Cancer Cell Int"},{"key":"4052_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrg.2018.9","volume":"19","author":"Y Ge","year":"2018","unstructured":"Ge Y, Fuchs E. Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer. Nat Rev Genet. 2018;19:311\u201325. https:\/\/doi.org\/10.1038\/nrg.2018.9.","journal-title":"Nat Rev Genet"},{"key":"4052_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcell.2019.00086","volume":"7","author":"S Nallanthighal","year":"2019","unstructured":"Nallanthighal S, Heiserman JP, Cheon D-J. The role of the extracellular matrix in cancer stemness. Front Cell Dev Biol. 2019;7:86. https:\/\/doi.org\/10.3389\/fcell.2019.00086.","journal-title":"Front Cell Dev Biol"},{"key":"4052_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2016.06.001","volume":"43","author":"C Chen","year":"2016","unstructured":"Chen C, Fingerhut JM, Yamashita YM. The ins(ide) and outs(ide) of asymmetric stem cell division. Curr Opin Cell Biol. 2016;43:1\u20136. https:\/\/doi.org\/10.1016\/j.ceb.2016.06.001.","journal-title":"Curr Opin Cell Biol"},{"key":"4052_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.cell.2018.11.039","volume":"175","author":"J Wang","year":"2018","unstructured":"Wang J, Wang L, Feng G, Wang Y, Li Y, Li X, Liu C, Jiao G, Huang C, Shi J, Zhou T, Chen Q, Liu Z, Li W, Zhou Q. Asymmetric expression of LincGET biases cell fate in Two-Cell mouse embryos. Cell. 2018;175:1887\u2013e190118. https:\/\/doi.org\/10.1016\/j.cell.2018.11.039.","journal-title":"Cell"},{"key":"4052_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12967-023-04575-9","volume":"21","author":"Y-R Li","year":"2023","unstructured":"Li Y-R, Fang Y, Lyu Z, Zhu Y, Yang L. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. J Transl Med. 2023;21:686. https:\/\/doi.org\/10.1186\/s12967-023-04575-9.","journal-title":"J Transl Med"},{"key":"4052_CR28","doi-asserted-by":"publisher","first-page":"116520","DOI":"10.1016\/j.lfs.2019.05.076","volume":"231","author":"M Najafi","year":"2019","unstructured":"Najafi M, Mortezaee K, Ahadi R. Cancer stem cell (a)symmetry & plasticity: tumorigenesis and therapy relevance. Life Sci. 2019;231:116520. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.076.","journal-title":"Life Sci"},{"key":"4052_CR29","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1080\/15384101.2018.1532254","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu Y, Siles L, Postigo A, Dean DC. Epigenetically distinct sister chromatids and asymmetric generation of tumor initiating cells. Cell Cycle. 2018;17:2221\u20139. https:\/\/doi.org\/10.1080\/15384101.2018.1532254.","journal-title":"Cell Cycle"},{"key":"4052_CR30","doi-asserted-by":"publisher","first-page":"e56404","DOI":"10.15252\/embr.202256404","volume":"24","author":"EH Zion","year":"2023","unstructured":"Zion EH, Ringwalt D, Rinaldi K, Kahney EW, Li Y, Chen X. Old and newly synthesized histones are asymmetrically distributed in Drosophila intestinal stem cell divisions. EMBO Rep. 2023;24:e56404. https:\/\/doi.org\/10.15252\/embr.202256404.","journal-title":"EMBO Rep"},{"key":"4052_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ceb.2020.08.003","volume":"67","author":"EH Zion","year":"2020","unstructured":"Zion EH, Chandrasekhara C, Chen X. Asymmetric inheritance of epigenetic States in asymmetrically dividing stem cells. Curr Opin Cell Biol. 2020;67:27\u201336. https:\/\/doi.org\/10.1016\/j.ceb.2020.08.003.","journal-title":"Curr Opin Cell Biol"},{"key":"4052_CR32","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/stem.707","volume":"29","author":"YH Huh","year":"2011","unstructured":"Huh YH, Sherley JL. Molecular cloaking of H2A.Z on mortal DNA chromosomes during nonrandom segregation. Stem Cells. 2011;29:1620\u20137. https:\/\/doi.org\/10.1002\/stem.707.","journal-title":"Stem Cells"},{"key":"4052_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tig.2019.10.004","volume":"36","author":"M Wooten","year":"2020","unstructured":"Wooten M, Ranjan R, Chen X. Asymmetric histone inheritance in asymmetrically dividing stem cells. Trends Genet. 2020;36:30\u201343. https:\/\/doi.org\/10.1016\/j.tig.2019.10.004.","journal-title":"Trends Genet"},{"key":"4052_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.tcb.2017.02.001","volume":"27","author":"J Xie","year":"2017","unstructured":"Xie J, Wooten M, Tran V, Chen X. Breaking Symmetry\u2009\u2013\u2009Asymmetric histone inheritance in stem cells. Trends Cell Biol. 2017;27:527\u201340. https:\/\/doi.org\/10.1016\/j.tcb.2017.02.001.","journal-title":"Trends Cell Biol"},{"key":"4052_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41594-019-0269-z","volume":"26","author":"M Wooten","year":"2019","unstructured":"Wooten M, Snedeker J, Nizami ZF, Yang X, Ranjan R, Urban E, Kim JM, Gall J, Xiao J, Chen X. Asymmetric histone inheritance via strand-specific incorporation and biased replication fork movement. Nat Struct Mol Biol. 2019;26:732\u201343. https:\/\/doi.org\/10.1038\/s41594-019-0269-z.","journal-title":"Nat Struct Mol Biol"},{"key":"4052_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2023.04.005","volume":"92","author":"RKME Alsayed","year":"2023","unstructured":"Alsayed RKME, Sheikhan KSAM, Alam MA, Buddenkotte J, Steinhoff M, Uddin S, Ahmad A. Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions. Sem Cancer Biol. 2023;92:74\u201383. https:\/\/doi.org\/10.1016\/j.semcancer.2023.04.005.","journal-title":"Sem Cancer Biol"},{"key":"4052_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.stem.2012.06.006","volume":"11","author":"G Kusek","year":"2012","unstructured":"Kusek G, Campbell M, Doyle F, Tenenbaum SA, Kiebler M, Temple S. Asymmetric segregation of the Double-Stranded RNA binding protein Staufen2 during mammalian neural stem cell divisions promotes lineage progression. Cell Stem Cell. 2012;11:505\u201316. https:\/\/doi.org\/10.1016\/j.stem.2012.06.006.","journal-title":"Cell Stem Cell"},{"key":"4052_CR38","doi-asserted-by":"publisher","first-page":"e31347","DOI":"10.7554\/eLife.31347","volume":"7","author":"L Landskron","year":"2018","unstructured":"Landskron L, Steinmann V, Bonnay F, Burkard TR, Steinmann J, Reichardt I, Harzer H, Laurenson A-S, Reichert H, Knoblich JA. The asymmetrically segregating LncRNA Cherub is required for transforming stem cells into malignant cells. eLife. 2018;7:e31347. https:\/\/doi.org\/10.7554\/eLife.31347.","journal-title":"eLife"},{"key":"4052_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/nar\/gkad1095","volume":"52","author":"H-F Chen","year":"2024","unstructured":"Chen H-F, Chang C-T, Hsu K-W, Peng P-H, Lai JC-Y, Hung M-C, Wu K-J. Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis. Nucleic Acids Res. 2024;52:154\u201365. https:\/\/doi.org\/10.1093\/nar\/gkad1095.","journal-title":"Nucleic Acids Res"},{"key":"4052_CR40","doi-asserted-by":"publisher","first-page":"100774","DOI":"10.1016\/j.bj.2024.100774","volume":"48","author":"H-F Chen","year":"2025","unstructured":"Chen H-F, Wu K-J. LncRNAs and asymmetric cell division: the epigenetic mechanisms. Biomedical J. 2025;48:100774. https:\/\/doi.org\/10.1016\/j.bj.2024.100774.","journal-title":"Biomedical J"},{"key":"4052_CR41","doi-asserted-by":"publisher","unstructured":"Li W (Jess), Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ, Tang DG. MicroRNA-34a: Potent tumor suppressor, cancer stem cell inhibitor, and potential anticancer therapeutic. Front. Cell Dev. Biol. 2021;9:640587. https:\/\/doi.org\/10.3389\/fcell.2021.640587","DOI":"10.3389\/fcell.2021.640587"},{"key":"4052_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/1873-3468.12078","volume":"590","author":"S Wang","year":"2016","unstructured":"Wang S, Wu X, Liu Y, Yuan J, Yang F, Huang J, Meng Q, Zhou C, Liu F, Ma J, Sun S, Zheng J, Wang F. Long noncoding RNA H19 inhibits the proliferation of fetal liver cells and the Wnt signaling pathway. FEBS Lett. 2016;590:559\u201370. https:\/\/doi.org\/10.1002\/1873-3468.12078.","journal-title":"FEBS Lett"},{"key":"4052_CR43","doi-asserted-by":"publisher","first-page":"116630","DOI":"10.1016\/j.lfs.2019.116630","volume":"232","author":"G Huang","year":"2019","unstructured":"Huang G, Wang M, Li X, Wu J, Chen S, Du N, Li K, Wang J, Xu C, Ren H, Tang S-C, Sun X. TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells. Life Sci. 2019;232:116630. https:\/\/doi.org\/10.1016\/j.lfs.2019.116630.","journal-title":"Life Sci"},{"key":"4052_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/gt.2017.98","volume":"25","author":"C Xu","year":"2018","unstructured":"Xu C, Xiao G, Zhang B, Wang M, Wang J, Liu D, Zhang J, Ren H, Sun X. CCAT1 stimulation of the symmetric division of NSCLC stem cells through activation of the Wnt signalling cascade. Gene Ther. 2018;25:4\u201312. https:\/\/doi.org\/10.1038\/gt.2017.98.","journal-title":"Gene Ther"},{"key":"4052_CR45","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/ijms24031828","volume":"24","author":"SA Ciafr\u00e8","year":"2023","unstructured":"Ciafr\u00e8 SA, Russo M, Michienzi A, Galardi S. Long noncoding RNAs and cancer stem cells: dangerous liaisons managing cancer. IJMS. 2023;24:1828. https:\/\/doi.org\/10.3390\/ijms24031828.","journal-title":"IJMS"},{"key":"4052_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jnutbio.2017.02.020","volume":"44","author":"J Zhu","year":"2017","unstructured":"Zhu J, Wang S, Chen Y, Li X, Jiang Y, Yang X, Li Y, Wang X, Meng Y, Zhu M, Ma X, Huang C, Wu R, Xie C, Geng S, Wu J, Zhong C, Han H. miR-19 targeting of GSK3\u03b2 mediates Sulforaphane suppression of lung cancer stem cells. J Nutr Biochem. 2017;44:80\u201391. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.02.020.","journal-title":"J Nutr Biochem"},{"key":"4052_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells9010008","volume":"9","author":"X Jiao","year":"2019","unstructured":"Jiao X, Qian X, Wu L, Li B, Wang Y, Kong X, Xiong L. MicroRNA: the impact on cancer stemness and therapeutic resistance. Cells. 2019;9:8. https:\/\/doi.org\/10.3390\/cells9010008.","journal-title":"Cells"},{"key":"4052_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13046-018-0927-8","volume":"37","author":"Y-S Ma","year":"2018","unstructured":"Ma Y-S, Lv Z-W, Yu F, Chang Z-Y, Cong X-L, Zhong X-M, Lu G-X, Zhu J, Fu D. MicroRNA-302a\/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7\/AKT axis. J Exp Clin Cancer Res. 2018;37:252. https:\/\/doi.org\/10.1186\/s13046-018-0927-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"4052_CR49","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1083\/jcb.201611197","volume":"216","author":"S B\u00f6ckler","year":"2017","unstructured":"B\u00f6ckler S, Chelius X, Hock N, Klecker T, Wolter M, Weiss M, Braun RJ, Westermann B. Fusion, fission, and transport control asymmetric inheritance of mitochondria and protein aggregates. J Cell Biol. 2017;216:2481\u201398. https:\/\/doi.org\/10.1083\/jcb.201611197.","journal-title":"J Cell Biol"},{"key":"4052_CR50","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood.2020009778","volume":"139","author":"D Loeffler","year":"2022","unstructured":"Loeffler D, Schneiter F, Wang W, Wehling A, Kull T, Lengerke C, Manz MG, Schroeder T. Asymmetric organelle inheritance predicts human blood stem cell fate. Blood. 2022;139:2011\u201323. https:\/\/doi.org\/10.1182\/blood.2020009778.","journal-title":"Blood"},{"key":"4052_CR51","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1182\/blood.2021012726","volume":"139","author":"M-D Filippi","year":"2022","unstructured":"Filippi M-D. Asymmetric division: the choice of fate for HuHSCs. Blood. 2022;139:1930\u20132. https:\/\/doi.org\/10.1182\/blood.2021012726.","journal-title":"Blood"},{"key":"4052_CR52","doi-asserted-by":"publisher","first-page":"eabl5792","DOI":"10.1126\/sciadv.abl5792","volume":"8","author":"B Bohl","year":"2022","unstructured":"Bohl B, Jabali A, Ladewig J, Koch P. Asymmetric Notch activity by differential inheritance of lysosomes in human neural stem cells. Sci Adv. 2022;8:eabl5792. https:\/\/doi.org\/10.1126\/sciadv.abl5792.","journal-title":"Sci Adv"},{"key":"4052_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5483\/BMBRep.2021.54.7.048","volume":"54","author":"HY Choi","year":"2021","unstructured":"Choi HY, Seok J, Kang G-H, Lim KM, Cho S-G. The role of NUMB\/NUMB isoforms in cancer stem cells. BMB Rep. 2021;54:335\u201343. https:\/\/doi.org\/10.5483\/BMBRep.2021.54.7.048.","journal-title":"BMB Rep"},{"key":"4052_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, Wang J, Zhang Y, Zhu D, Li L. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Sig Transduct Target Ther. 2024;9:128. https:\/\/doi.org\/10.1038\/s41392-024-01828-x.","journal-title":"Sig Transduct Target Ther"},{"key":"4052_CR55","doi-asserted-by":"publisher","first-page":"592616","DOI":"10.3389\/fcell.2020.592616","volume":"8","author":"M Orzechowska","year":"2020","unstructured":"Orzechowska M, Anusewicz D, Bednarek AK. Functional gene expression differentiation of the Notch signaling pathway in female reproductive tract Tissues-A comprehensive review with analysis. Front Cell Dev Biol. 2020;8:592616. https:\/\/doi.org\/10.3389\/fcell.2020.592616.","journal-title":"Front Cell Dev Biol"},{"key":"4052_CR56","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/cancers13040768","volume":"13","author":"D Anusewicz","year":"2021","unstructured":"Anusewicz D, Orzechowska M, Bednarek AK. Notch signaling pathway in Cancer\u2014Review with bioinformatic analysis. Cancers. 2021;13:768. https:\/\/doi.org\/10.3390\/cancers13040768.","journal-title":"Cancers"},{"key":"4052_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/biomedicines7010017","volume":"7","author":"MB Sonbol","year":"2019","unstructured":"Sonbol MB, Ahn DH, Bekaii-Saab T. Therapeutic targeting strategies of cancer stem cells in Gastrointestinal malignancies. Biomedicines. 2019;7:17. https:\/\/doi.org\/10.3390\/biomedicines7010017.","journal-title":"Biomedicines"},{"key":"4052_CR58","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/cells12020333","volume":"12","author":"SM Ortega-Campos","year":"2023","unstructured":"Ortega-Campos SM, Garc\u00eda-Heredia JM. The multitasker protein: A look at the multiple capabilities of NUMB. Cells. 2023;12:333. https:\/\/doi.org\/10.3390\/cells12020333.","journal-title":"Cells"},{"key":"4052_CR59","doi-asserted-by":"publisher","first-page":"108215","DOI":"10.1016\/j.jbc.2025.108215","volume":"301","author":"SE Dho","year":"2025","unstructured":"Dho SE, Othman K, Zhang Y, McGlade CJ. NUMB alternative splicing and isoform-specific functions in development and disease. J Biol Chem. 2025;301:108215. https:\/\/doi.org\/10.1016\/j.jbc.2025.108215.","journal-title":"J Biol Chem"},{"key":"4052_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13287-020-01703-w","volume":"11","author":"M Forouzanfar","year":"2020","unstructured":"Forouzanfar M, Lachinani L, Dormiani K, Nasr-Esfahani MH, Gure AO, Ghaedi K. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells. Stem Cell Res Ther. 2020;11:193. https:\/\/doi.org\/10.1186\/s13287-020-01703-w.","journal-title":"Stem Cell Res Ther"},{"key":"4052_CR61","doi-asserted-by":"publisher","first-page":"18300","DOI":"10.1038\/s41598-020-75171-w","volume":"10","author":"EJ Orzechowska","year":"2020","unstructured":"Orzechowska EJ, Katano T, Bialkowska AB, Yang VW. Interplay among p21Waf1\/Cip1, MUSASHI-1 and Kr\u00fcppel-like factor 4 in activation of Bmi1-CreER reserve intestinal stem cells after gamma radiation-induced injury. Sci Rep. 2020;10:18300. https:\/\/doi.org\/10.1038\/s41598-020-75171-w.","journal-title":"Sci Rep"},{"key":"4052_CR62","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1476-4598-9-221","volume":"9","author":"X-Y Wang","year":"2010","unstructured":"Wang X-Y, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H, Glazer RI. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol Cancer. 2010;9:221. https:\/\/doi.org\/10.1186\/1476-4598-9-221.","journal-title":"Mol Cancer"},{"key":"4052_CR63","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1007\/s00432-021-03743-y","volume":"147","author":"FM Troschel","year":"2021","unstructured":"Troschel FM, Palenta H, Borrmann K, Heshe K, Hua SH, Yip GW, Kiesel L, Eich HT, G\u00f6tte M, Greve B. Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1\/CIP1. J Cancer Res Clin Oncol. 2021;147:3299\u2013312. https:\/\/doi.org\/10.1007\/s00432-021-03743-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4052_CR64","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/biology10050407","volume":"10","author":"N Bley","year":"2021","unstructured":"Bley N, Hmedat A, M\u00fcller S, Rolnik R, Rausch A, Lederer M, H\u00fcttelmaier S. Musashi\u20131\u2014A Stemness RBP Cancer Therapy? Biology. 2021;10:407. https:\/\/doi.org\/10.3390\/biology10050407.","journal-title":"Musashi\u20131\u2014A Stemness RBP Cancer Therapy? Biology"},{"key":"4052_CR65","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41375-020-01115-y","volume":"35","author":"F Palacios","year":"2021","unstructured":"Palacios F, Yan X-J, Ferrer G, Chen S-S, Vergani S, Yang X, Gardner J, Barrientos JC, Rock P, Burack R, Kolitz JE, Allen SL, Kharas MG, Abdel-Wahab O, Rai KR, Chiorazzi N. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target. Leukemia. 2021;35:1037\u201352. https:\/\/doi.org\/10.1038\/s41375-020-01115-y.","journal-title":"Leukemia"},{"key":"4052_CR66","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-023-04106-6","volume":"21","author":"F Li","year":"2023","unstructured":"Li F, Han Y, Chen R, Jiang Y, Chen C, Wang X, Zhou J, Xu Q, Jiang S, Zhang S, Yu K, Zhang S. MicroRNA-143 acts as a tumor suppressor through Musashi-2\/DLL1\/Notch1 and Musashi-2\/Snail1\/MMPs axes in acute myeloid leukemia. J Transl Med. 2023;21:309. https:\/\/doi.org\/10.1186\/s12967-023-04106-6.","journal-title":"J Transl Med"},{"key":"4052_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Sig Transduct Target Ther. 2022;7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6.","journal-title":"Sig Transduct Target Ther"},{"key":"4052_CR68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13237-019-00281-4","volume":"62","author":"S Paul","year":"2019","unstructured":"Paul S, Dutta A, Basak U, Dutta A, Das A, Chakraborty S, Bhattacharya A, Banerjee S, Sengupta D, Mazumdar D, Guha D, Mukherjee S, Das T. Cancer stem cell fate determination: a nuclear phenomenon. Nucleus. 2019;62:109\u201318. https:\/\/doi.org\/10.1007\/s13237-019-00281-4.","journal-title":"Nucleus"},{"key":"4052_CR69","doi-asserted-by":"publisher","first-page":"111118","DOI":"10.1016\/j.isci.2024.111118","volume":"27","author":"S Manzanero-Ortiz","year":"2024","unstructured":"Manzanero-Ortiz S, Franco M, Laxmeesha M, Carmena A. Drosophila p53 tumor suppressor directly activates conserved asymmetric stem cell division regulators. iScience. 2024;27:111118. https:\/\/doi.org\/10.1016\/j.isci.2024.111118.","journal-title":"iScience"},{"key":"4052_CR70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.devcel.2012.11.014","volume":"24","author":"S Chen","year":"2013","unstructured":"Chen S, Chen J, Shi H, Wei M, Castaneda-Castellanos DR, Bultje RS, Pei X, Kriegstein AR, Zhang M, Shi S-H. Regulation of microtubule stability and organization by mammalian Par3 in specifying neuronal Polarity. Dev Cell. 2013;24:26\u201340. https:\/\/doi.org\/10.1016\/j.devcel.2012.11.014.","journal-title":"Dev Cell"},{"key":"4052_CR71","doi-asserted-by":"publisher","first-page":"570815","DOI":"10.3389\/fonc.2020.570815","volume":"10","author":"H Izumi","year":"2020","unstructured":"Izumi H, Kaneko Y, Nakagawara A. The role of MYCN in symmetric vs. Asymmetric cell division of human neuroblastoma cells. Front Oncol. 2020;10:570815. https:\/\/doi.org\/10.3389\/fonc.2020.570815.","journal-title":"Front Oncol"},{"key":"4052_CR72","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1007\/s11033-021-06809-9","volume":"48","author":"MDA Rainho","year":"2021","unstructured":"Rainho MDA, Mencalha AL, Thole AA. Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review. Mol Biol Rep. 2021;48:7527\u201335. https:\/\/doi.org\/10.1007\/s11033-021-06809-9.","journal-title":"Mol Biol Rep"},{"key":"4052_CR73","doi-asserted-by":"publisher","first-page":"1227884","DOI":"10.3389\/fonc.2023.1227884","volume":"13","author":"GM Abd","year":"2023","unstructured":"Abd GM, Laird MC, Ku JC, Li Y. Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. Front Oncol. 2023;13:1227884. https:\/\/doi.org\/10.3389\/fonc.2023.1227884.","journal-title":"Front Oncol"},{"key":"4052_CR74","doi-asserted-by":"publisher","first-page":"1078768","DOI":"10.3389\/fonc.2023.1078768","volume":"13","author":"M Guo","year":"2023","unstructured":"Guo M, Niu Y, Xie M, Liu X, Li X. Notch signaling, hypoxia, and cancer. Front Oncol. 2023;13:1078768. https:\/\/doi.org\/10.3389\/fonc.2023.1078768.","journal-title":"Front Oncol"},{"key":"4052_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Sig Transduct Target Ther. 2024;9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Sig Transduct Target Ther"},{"key":"4052_CR76","doi-asserted-by":"publisher","first-page":"17258","DOI":"10.3390\/ijms242417258","volume":"24","author":"LG Marcu","year":"2023","unstructured":"Marcu LG, Dell\u2019Oro M, Bezak E. Opportunities in cancer therapies: Deciphering the role of cancer stem cells in tumour repopulation. IJMS. 2023;24:17258. https:\/\/doi.org\/10.3390\/ijms242417258.","journal-title":"IJMS"},{"key":"4052_CR77","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0167","author":"A Gr\u00fcn","year":"2020","unstructured":"Gr\u00fcn A, Kuhnt T, Schlomm T, Olze H, Budach V, Stromberger C. Repeat radiation for local recurrence of head and neck tumors and in prostate cancer. Deutsches \u00c4rzteblatt International. 2020. https:\/\/doi.org\/10.3238\/arztebl.2020.0167.","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"4052_CR78","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/jnci\/djj495","volume":"98","author":"TM Phillips","year":"2006","unstructured":"Phillips TM, McBride WH, Pajonk F. The response of CD24 \u2013\/low \/CD44\u2009+\u2009Breast Cancer\u2013Initiating cells to radiation. JNCI: J Natl Cancer Inst. 2006;98:1777\u201385. https:\/\/doi.org\/10.1093\/jnci\/djj495.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"4052_CR79","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1158\/0008-5472.CAN-15-3198","volume":"76","author":"T Srinivasan","year":"2016","unstructured":"Srinivasan T, Walters J, Bu P, Than EB, Tung K-L, Chen K-Y, Panarelli N, Milsom J, Augenlicht L, Lipkin SM, Shen X. NOTCH signaling regulates asymmetric cell fate of Fast- and Slow-Cycling colon Cancer\u2013Initiating cells. Cancer Res. 2016;76:3411\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3198.","journal-title":"Cancer Res"},{"key":"4052_CR80","doi-asserted-by":"publisher","first-page":"155709","DOI":"10.1016\/j.cyto.2021.155709","volume":"148","author":"J Wang","year":"2021","unstructured":"Wang J, Xu Z, Wang Z, Du G, Lun L. TGF-beta signaling in cancer radiotherapy. Cytokine. 2021;148:155709. https:\/\/doi.org\/10.1016\/j.cyto.2021.155709.","journal-title":"Cytokine"},{"key":"4052_CR81","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao L, Li X-F. Hypoxia and the tumor microenvironment. Technol Cancer Res Treat. 2021;20:15330338211036304. https:\/\/doi.org\/10.1177\/15330338211036304.","journal-title":"Technol Cancer Res Treat"},{"key":"4052_CR82","doi-asserted-by":"publisher","first-page":"122890","DOI":"10.1016\/j.lfs.2024.122890","volume":"352","author":"N Taneja","year":"2024","unstructured":"Taneja N, Chauhan A, Kulshreshtha R, Singh S. HIF-1 mediated metabolic reprogramming in cancer: mechanisms and therapeutic implications. Life Sci. 2024;352:122890. https:\/\/doi.org\/10.1016\/j.lfs.2024.122890.","journal-title":"Life Sci"},{"key":"4052_CR83","doi-asserted-by":"publisher","first-page":"1609082","DOI":"10.3389\/fcell.2025.1609082","volume":"13","author":"WV Jaraba-\u00c1lvarez","year":"2025","unstructured":"Jaraba-\u00c1lvarez WV, Uscanga-Palomeque AC, Sanchez-Giraldo V, Madrid C, Ortega-Arellano H, Halpert K, Quintero-Gil C. Hypoxia-induced metabolic reprogramming in mesenchymal stem cells: unlocking the regenerative potential of secreted factors. Front Cell Dev Biol. 2025;13:1609082. https:\/\/doi.org\/10.3389\/fcell.2025.1609082.","journal-title":"Front Cell Dev Biol"},{"key":"4052_CR84","doi-asserted-by":"publisher","unstructured":"Tang Y-A, Chen Y, Bao Y, Mahara S, Yatim SMJM, Oguz G, Lee PL, Feng M, Cai Y, Tan EY, Fong SS, Yang Z, Lan P, Wu X, Yu Q. Hypoxic tumor microenvironment activates GLI2 via HIF-1\u03b1 and TGF-\u03b22 to promote chemoresistance in colorectal cancer. Proc Natl Acad Sci U S A. 2018;115. https:\/\/doi.org\/10.1073\/pnas.1801348115.","DOI":"10.1073\/pnas.1801348115"},{"key":"4052_CR85","doi-asserted-by":"publisher","unstructured":"Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A. 2010;107:2195\u20132200. https:\/\/doi.org\/10.1073\/pnas.0909390107","DOI":"10.1073\/pnas.0909390107"},{"key":"4052_CR86","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1242\/dev.079665","volume":"139","author":"W Liu","year":"2012","unstructured":"Liu W, Wen Y, Bi P, Lai X, Liu XS, Liu X, Kuang S. Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development. 2012;139:2857\u201365. https:\/\/doi.org\/10.1242\/dev.079665.","journal-title":"Development"},{"key":"4052_CR87","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1574888X09666131230142459","volume":"9","author":"J Shang","year":"2014","unstructured":"Shang J, Liu H, Li J, Zhou Y. Roles of hypoxia during the chondrogenic differentiation of mesenchymal stem cells. CSCR. 2014;9:141\u20137. https:\/\/doi.org\/10.2174\/1574888X09666131230142459.","journal-title":"CSCR"},{"key":"4052_CR88","doi-asserted-by":"publisher","first-page":"12505","DOI":"10.1038\/s41598-020-68668-x","volume":"10","author":"EZ White","year":"2020","unstructured":"White EZ, Pennant NM, Carter JR, Hawsawi O, Odero-Marah V, Hinton CV. Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells. Sci Rep. 2020;10:12505. https:\/\/doi.org\/10.1038\/s41598-020-68668-x.","journal-title":"Sci Rep"},{"key":"4052_CR89","doi-asserted-by":"publisher","first-page":"1472772","DOI":"10.3389\/fimmu.2024.1472772","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang L, Zhang Z, Wu P, Zhang Y, Chen X. Advances in targeting tumor microenvironment for immunotherapy. Front Immunol. 2024;15:1472772. https:\/\/doi.org\/10.3389\/fimmu.2024.1472772.","journal-title":"Front Immunol"},{"key":"4052_CR90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3934\/molsci.2020006","volume":"7","author":"S Majumdar","year":"2020","unstructured":"Majumdar S, Liu S-T. Department of biological Sciences, university of Toledo, Toledo, OH 43606, USA: cell division symmetry control and cancer stem cells. AIMS Mol Sci. 2020;7:82\u2013101. https:\/\/doi.org\/10.3934\/molsci.2020006.","journal-title":"AIMS Mol Sci"},{"key":"4052_CR91","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12672-024-01049-2","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang L, Wei Y, Wei C, Yang H, Chen Q, Zhang R, Shen H. Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy. Discov Onc. 2024;15:184. https:\/\/doi.org\/10.1007\/s12672-024-01049-2.","journal-title":"Discov Onc"},{"key":"4052_CR92","doi-asserted-by":"publisher","first-page":"1410637","DOI":"10.3389\/fcell.2024.1410637","volume":"12","author":"P Liu","year":"2024","unstructured":"Liu P, Wang L, Yu H. Polyploid giant cancer cells: origin, possible pathways of formation, characteristics, and mechanisms of regulation. Front Cell Dev Biol. 2024;12:1410637. https:\/\/doi.org\/10.3389\/fcell.2024.1410637.","journal-title":"Front Cell Dev Biol"},{"key":"4052_CR93","doi-asserted-by":"publisher","first-page":"103920","DOI":"10.1016\/j.critrevonc.2023.103920","volume":"182","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi N, Afshinpour M, Fakhr SS, Kalkhoran PG, Shadman-Manesh V, Adelian S, Beiranvand S, Rezaei-Tazangi F, Khorram R, Hamblin MR, Aref AR. Cancer stem cells in colorectal cancer: signaling pathways involved in stemness and therapy resistance. Crit Rev Oncol\/Hematol. 2023;182:103920. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103920.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"4052_CR94","doi-asserted-by":"publisher","first-page":"1231416","DOI":"10.3389\/fcell.2023.1231416","volume":"11","author":"M Brisset","year":"2023","unstructured":"Brisset M, Mehlen P, Meurette O, Hollande F. Notch receptor\/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. Front Cell Dev Biol. 2023;11:1231416. https:\/\/doi.org\/10.3389\/fcell.2023.1231416.","journal-title":"Front Cell Dev Biol"},{"key":"4052_CR95","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2012.04.036","volume":"21","author":"CA O\u2019Brien","year":"2012","unstructured":"O\u2019Brien CA, Kreso A, Ryan P, Hermans KG, Gibson L, Wang Y, Tsatsanis A, Gallinger S, Dick JE. ID1 and ID3 regulate the Self-Renewal capacity of human colon Cancer-Initiating cells through p21. Cancer Cell. 2012;21:777\u201392. https:\/\/doi.org\/10.1016\/j.ccr.2012.04.036.","journal-title":"Cancer Cell"},{"key":"4052_CR96","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12935-024-03338-w","volume":"24","author":"W Gao","year":"2024","unstructured":"Gao W, Zhou J, Morshedi M. MicroRNA-34 and Gastrointestinal cancers: a player with big functions. Cancer Cell Int. 2024;24:163. https:\/\/doi.org\/10.1186\/s12935-024-03338-w.","journal-title":"Cancer Cell Int"},{"key":"4052_CR97","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.3390\/ijms25073585","volume":"25","author":"GK Oyejobi","year":"2024","unstructured":"Oyejobi GK, Yan X, Sliz P, Wang L. Regulating Protein\u2013RNA interactions: advances in targeting the LIN28\/Let-7 pathway. IJMS. 2024;25:3585. https:\/\/doi.org\/10.3390\/ijms25073585.","journal-title":"IJMS"},{"key":"4052_CR98","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jds.2022.09.001","volume":"18","author":"Y-T Liu","year":"2023","unstructured":"Liu Y-T, Yu C-C, Lu M-Y, Chao S-C, Liao Y-W, Yu C-H, Lee Y-H. miR-146a participates in the regulation of cancer stemness of oral carcinoma cells. J Dent Sci. 2023;18:503\u20139. https:\/\/doi.org\/10.1016\/j.jds.2022.09.001.","journal-title":"J Dent Sci"},{"key":"4052_CR99","doi-asserted-by":"publisher","first-page":"26069","DOI":"10.1038\/srep26069","volume":"6","author":"T Srinivasan","year":"2016","unstructured":"Srinivasan T, Than EB, Bu P, Tung K-L, Chen K-Y, Augenlicht L, Lipkin SM, Shen X. Notch signalling regulates asymmetric division and inter-conversion between lgr5 and bmi1 expressing intestinal stem cells. Sci Rep. 2016;6:26069. https:\/\/doi.org\/10.1038\/srep26069.","journal-title":"Sci Rep"},{"key":"4052_CR100","doi-asserted-by":"publisher","unstructured":"Burko P, D\u2019Amico G, Miltykh I, Scalia F, De Macario C, Macario E, Giglia AJL, Cappello G, Bavisotto FC. C.: Molecular pathways implicated in radioresistance of glioblastoma multiforme: what is the role of extracellular vesicles? IJMS. 24, 4883 (2023). https:\/\/doi.org\/10.3390\/ijms24054883","DOI":"10.3390\/ijms24054883"},{"key":"4052_CR101","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/onc.2014.92","volume":"34","author":"I Bandey","year":"2015","unstructured":"Bandey I, Chiou S-H, Huang A-P, Tsai J-C, Tu P. Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness. Oncogene. 2015;34:1853\u201364. https:\/\/doi.org\/10.1038\/onc.2014.92.","journal-title":"Oncogene"},{"key":"4052_CR102","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12015-023-10647-6","volume":"20","author":"AP Moreno-Londo\u00f1o","year":"2024","unstructured":"Moreno-Londo\u00f1o AP, Robles-Flores M. Functional roles of CD133: more than stemness associated factor regulated by the microenvironment. Stem Cell Rev Rep. 2024;20:25\u201351. https:\/\/doi.org\/10.1007\/s12015-023-10647-6.","journal-title":"Stem Cell Rev Rep"},{"key":"4052_CR103","doi-asserted-by":"publisher","first-page":"e130510","DOI":"10.1172\/jci.insight.130510","volume":"6","author":"M Hitomi","year":"2021","unstructured":"Hitomi M, Chumakova AP, Silver DJ, Knudsen AM, Pontius WD, Murphy S, Anand N, Kristensen BW, Lathia JD. Asymmetric cell division promotes therapeutic resistance in glioblastoma stem cells. JCI Insight. 2021;6:e130510. https:\/\/doi.org\/10.1172\/jci.insight.130510.","journal-title":"JCI Insight"},{"key":"4052_CR104","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-14-3689","volume":"75","author":"RG Lerner","year":"2015","unstructured":"Lerner RG, Grossauer S, Kadkhodaei B, Meyers I, Sidorov M, Koeck K, Hashizume R, Ozawa T, Phillips JJ, Berger MS, Nicolaides T, James CD, Petritsch CK. Targeting a Plk1-Controlled Polarity checkpoint in Therapy-Resistant Glioblastoma-Propagating cells. Cancer Res. 2015;75:5355\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3689.","journal-title":"Cancer Res"},{"key":"4052_CR105","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1038\/s41467-022-32448-0","volume":"13","author":"F Antonica","year":"2022","unstructured":"Antonica F, Santomaso L, Pernici D, Petrucci L, Aiello G, Cutarelli A, Conti L, Romanel A, Miele E, Tebaldi T, Tiberi L. A slow-cycling\/quiescent cells subpopulation is involved in glioma invasiveness. Nat Commun. 2022;13:4767. https:\/\/doi.org\/10.1038\/s41467-022-32448-0.","journal-title":"Nat Commun"},{"key":"4052_CR106","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.cell.2020.06.027","volume":"182","author":"W Huang","year":"2020","unstructured":"Huang W, Bhaduri A, Velmeshev D, Wang S, Wang L, Rottkamp CA, Alvarez-Buylla A, Rowitch DH, Kriegstein AR. Origins and proliferative States of human oligodendrocyte precursor cells. Cell. 2020;182:594\u2013e60811. https:\/\/doi.org\/10.1016\/j.cell.2020.06.027.","journal-title":"Cell"},{"key":"4052_CR107","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10555-022-10051-5","volume":"41","author":"R Sun","year":"2022","unstructured":"Sun R, Kim AH. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. Cancer Metastasis Rev. 2022;41:871\u201398. https:\/\/doi.org\/10.1007\/s10555-022-10051-5.","journal-title":"Cancer Metastasis Rev"},{"key":"4052_CR108","doi-asserted-by":"publisher","first-page":"1373554","DOI":"10.3389\/frhem.2024.1373554","volume":"3","author":"J Nunes","year":"2024","unstructured":"Nunes J, Loeffler D. Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives. Front Hematol. 2024;3:1373554. https:\/\/doi.org\/10.3389\/frhem.2024.1373554.","journal-title":"Front Hematol"},{"key":"4052_CR109","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/biom11070936","volume":"11","author":"Y Wu","year":"2021","unstructured":"Wu Y, Zeng L, Zhao S. Ligands of adrenergic receptors: A structural point of view. Biomolecules. 2021;11:936. https:\/\/doi.org\/10.3390\/biom11070936.","journal-title":"Biomolecules"},{"key":"4052_CR110","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41375-023-02005-9","volume":"37","author":"T Eifert","year":"2023","unstructured":"Eifert T, Hsu C-J, Becker AL, Graessle S, Horne A, Bemmann F, Zhang Q, Heuser M, Vasioukhin V, Scholl S, Hochhaus A, Siegerist F, Endlich N, Bullinger L, Lane SW, Haas S, Schnoeder TM, Heidel FH. Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. Leukemia. 2023;37:2027\u201335. https:\/\/doi.org\/10.1038\/s41375-023-02005-9.","journal-title":"Leukemia"},{"key":"4052_CR111","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.gendis.2023.01.008","volume":"11","author":"S Azizidoost","year":"2024","unstructured":"Azizidoost S, Nasrolahi A, Sheykhi-Sabzehpoush M, Anbiyaiee A, Khoshnam SE, Farzaneh M, Uddin S. Signaling pathways governing the behaviors of leukemia stem cells. Genes Dis. 2024;11:830\u201346. https:\/\/doi.org\/10.1016\/j.gendis.2023.01.008.","journal-title":"Genes Dis"},{"key":"4052_CR112","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.2889","volume":"46","author":"B Zimdahl","year":"2014","unstructured":"Zimdahl B, Ito T, Blevins A, Bajaj J, Konuma T, Weeks J, Koechlein CS, Kwon HY, Arami O, Rizzieri D, Broome HE, Chuah C, Oehler VG, Sasik R, Hardiman G, Reya T. Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia. Nat Genet. 2014;46:245\u201352. https:\/\/doi.org\/10.1038\/ng.2889.","journal-title":"Nat Genet"},{"key":"4052_CR113","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1158\/1541-7786.MCR-14-0474","volume":"13","author":"I Dey-Guha","year":"2015","unstructured":"Dey-Guha I, Alves CP, Yeh AC, Salony, Sole X, Darp R, Ramaswamy S. A mechanism for asymmetric cell division resulting in proliferative asynchronicity. Mol Cancer Res. 2015;13:223\u201330. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0474.","journal-title":"Mol Cancer Res"},{"key":"4052_CR114","doi-asserted-by":"publisher","unstructured":"Tominaga K. Signaling factors involved in Self-Renewal of breast cancer Stem-like cells. Cancer Stud. 2018;2. https:\/\/doi.org\/10.31532\/CancerStud.2.1.003.","DOI":"10.31532\/CancerStud.2.1.003"},{"key":"4052_CR115","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2021.04.021","volume":"78","author":"S Basu","year":"2022","unstructured":"Basu S, Dong Y, Kumar R, Jeter C, Tang DG. Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Sem Cancer Biol. 2022;78:90\u2013103. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.021.","journal-title":"Sem Cancer Biol"},{"key":"4052_CR116","doi-asserted-by":"publisher","first-page":"604124","DOI":"10.3389\/fonc.2020.604124","volume":"10","author":"D Ghatak","year":"2020","unstructured":"Ghatak D, Das Ghosh D, Roychoudhury S. Cancer stemness: p53 at the wheel. Front Oncol. 2020;10:604124. https:\/\/doi.org\/10.3389\/fonc.2020.604124.","journal-title":"Front Oncol"},{"key":"4052_CR117","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, Wang Q, Li Y, Hu F, Ren H. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23:261. https:\/\/doi.org\/10.1186\/s12943-024-02165-x.","journal-title":"Mol Cancer"},{"key":"4052_CR118","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccell.2016.02.012","volume":"29","author":"SA Ali","year":"2016","unstructured":"Ali SA, Justilien V, Jamieson L, Murray NR, Fields AP. Protein kinase C\u03b9 drives a NOTCH3-dependent Stem-like phenotype in mutant KRAS lung adenocarcinoma. Cancer Cell. 2016;29:367\u201378. https:\/\/doi.org\/10.1016\/j.ccell.2016.02.012.","journal-title":"Cancer Cell"},{"key":"4052_CR119","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.4251\/wjgo.v13.i11.1648","volume":"13","author":"X Lv","year":"2021","unstructured":"Lv X, Xu G. Regulatory role of the transforming growth factor-\u03b2 signaling pathway in the drug resistance of Gastrointestinal cancers. WJGO. 2021;13:1648\u201367. https:\/\/doi.org\/10.4251\/wjgo.v13.i11.1648.","journal-title":"WJGO"},{"key":"4052_CR120","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1080\/15384101.2023.2206502","volume":"22","author":"SP Pitzen","year":"2023","unstructured":"Pitzen SP, Dehm SM. Basal epithelial cells in prostate development, tumorigenesis, and cancer progression. Cell Cycle. 2023;22:1303\u201318. https:\/\/doi.org\/10.1080\/15384101.2023.2206502.","journal-title":"Cell Cycle"},{"key":"4052_CR121","doi-asserted-by":"publisher","first-page":"1521204","DOI":"10.3389\/fonc.2025.1521204","volume":"15","author":"FC Bugoye","year":"2025","unstructured":"Bugoye FC, Torrorey-Sawe R, Biegon R, Dharsee N, Mafumiko F, Kibona H, Aboud S, Patel K, Mining S. Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management. Front Oncol. 2025;15:1521204. https:\/\/doi.org\/10.3389\/fonc.2025.1521204.","journal-title":"Front Oncol"},{"key":"4052_CR122","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.stem.2012.03.009","volume":"10","author":"J Qin","year":"2012","unstructured":"Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG. The PSA(-\/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell. 2012;10:556\u201369. https:\/\/doi.org\/10.1016\/j.stem.2012.03.009.","journal-title":"Cell Stem Cell"},{"key":"4052_CR123","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-025-02345-3","volume":"24","author":"H Alizadeh","year":"2025","unstructured":"Alizadeh H, Akbarabadi P, Dadfar A, Tareh MR, Soltani B. A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities. Mol Cancer. 2025;24:135. https:\/\/doi.org\/10.1186\/s12943-025-02345-3.","journal-title":"Mol Cancer"},{"key":"4052_CR124","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/ijpm.ijpm_467_23","volume":"67","author":"L Mallika","year":"2024","unstructured":"Mallika L, Rajarathinam M, Thangavel S. Cancer stem cells in head and neck squamous cell carcinoma and its associated markers: A review. Indian J Pathol Microbiol. 2024;67:250\u20138. https:\/\/doi.org\/10.4103\/ijpm.ijpm_467_23.","journal-title":"Indian J Pathol Microbiol"},{"key":"4052_CR125","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/molecules26040972","volume":"26","author":"M Ghanbari-Movahed","year":"2021","unstructured":"Ghanbari-Movahed M, Ghanbari-Movahed Z, Momtaz S, Kilpatrick KL, Farzaei MH, Bishayee A. Unlocking the secrets of cancer stem cells with \u03b3-Secretase inhibitors: A novel anticancer strategy. Molecules. 2021;26:972. https:\/\/doi.org\/10.3390\/molecules26040972.","journal-title":"Molecules"},{"key":"4052_CR126","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4252\/wjsc.v11.i7.398","volume":"11","author":"F-Y Du","year":"2019","unstructured":"Du F-Y, Zhou Q-F, Sun W-J, Chen G-L. Targeting cancer stem cells in drug discovery: current state and future perspectives. WJSC. 2019;11:398\u2013420. https:\/\/doi.org\/10.4252\/wjsc.v11.i7.398.","journal-title":"WJSC"},{"key":"4052_CR127","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-014-1630-z","volume":"121","author":"S Tanaka","year":"2015","unstructured":"Tanaka S, Nakada M, Yamada D, Nakano I, Todo T, Ino Y, Hoshii T, Tadokoro Y, Ohta K, Ali MAE, Hayashi Y, Hamada J, Hirao A. Strong therapeutic potential of \u03b3-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells. J Neurooncol. 2015;121:239\u201350. https:\/\/doi.org\/10.1007\/s11060-014-1630-z.","journal-title":"J Neurooncol"},{"key":"4052_CR128","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1158\/1078-0432.CCR-18-2732","volume":"25","author":"W Fu","year":"2019","unstructured":"Fu W, Lei C, Yu Y, Liu S, Li T, Lin F, Fan X, Shen Y, Ding M, Tang Y, Ye X, Yang Y, Hu S. EGFR\/Notch antagonists enhance the response to inhibitors of the PI3K-Akt pathway by decreasing Tumor-Initiating cell frequency. Clin Cancer Res. 2019;25:2835\u201347. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2732.","journal-title":"Clin Cancer Res"},{"key":"4052_CR129","doi-asserted-by":"publisher","unstructured":"Qu Y, Gharbi N, Yuan X, Olsen JR, Blicher P, Dalhus B, Brokstad KA, Lin B, \u00d8yan AM, Zhang W, Kalland K-H, Ke X. Axitinib blocks Wnt\/\u03b2-catenin signaling and directs asymmetric cell division in cancer. Proc Natl Acad Sci USA. 2016;113:9339\u20139344. https:\/\/doi.org\/10.1073\/pnas.1604520113.","DOI":"10.1073\/pnas.1604520113"},{"key":"4052_CR130","doi-asserted-by":"publisher","first-page":"14123","DOI":"10.1002\/jcp.28104","volume":"234","author":"F Rahmani","year":"2019","unstructured":"Rahmani F, Amerizadeh F, Hassanian SM, Hashemzehi M, Nasiri S, Fiuji H, Ferns GA, Khazaei M, Avan A. RETRACTED: PNU-74654 enhances the antiproliferative effects of 5\u2010FU in breast cancer and antagonizes thrombin\u2010induced cell growth via the Wnt pathway. J Cell Physiol. 2019;234:14123\u201332. https:\/\/doi.org\/10.1002\/jcp.28104.","journal-title":"J Cell Physiol"},{"key":"4052_CR131","doi-asserted-by":"publisher","first-page":"33982","DOI":"10.18632\/oncotarget.26125","volume":"9","author":"DB Bernkopf","year":"2018","unstructured":"Bernkopf DB, Daum G, Br\u00fcckner M, Behrens J. Sulforaphane inhibits growth and blocks Wnt\/\u03b2-catenin signaling of colorectal cancer cells. Oncotarget. 2018;9:33982\u201394. https:\/\/doi.org\/10.18632\/oncotarget.26125.","journal-title":"Oncotarget"},{"key":"4052_CR132","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2016.07.013","volume":"381","author":"H-H Lin","year":"2016","unstructured":"Lin H-H, Feng W-C, Lu L-C, Shao Y-Y, Hsu C-H, Cheng A-L. Inhibition of the Wnt\/\u03b2-catenin signaling pathway improves the anti-tumor effects of Sorafenib against hepatocellular carcinoma. Cancer Lett. 2016;381:58\u201366. https:\/\/doi.org\/10.1016\/j.canlet.2016.07.013.","journal-title":"Cancer Lett"},{"key":"4052_CR133","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-025-07789-5","volume":"16","author":"Y He","year":"2025","unstructured":"He Y, Liu D, Ling A, Han Z, Cui J, Cheng J, Feng Y, Liu W, Gong W, Xia Y, Chen L, Luo Y, Wang Y, Tian X, Wu Q, Chen L, Guo H. Inhibition of Wnt\/\u03b2-catenin increases anti-tumor activity by synergizing with Sorafenib in hepatocellular carcinoma. Cell Death Dis. 2025;16:466. https:\/\/doi.org\/10.1038\/s41419-025-07789-5.","journal-title":"Cell Death Dis"},{"key":"4052_CR134","doi-asserted-by":"publisher","first-page":"101853","DOI":"10.1016\/j.tice.2022.101853","volume":"77","author":"F Amerizadeh","year":"2022","unstructured":"Amerizadeh F, Rahmani F, Maftooh M, Nasiri S-N, Hassanian SM, Giovannetti E, Moradi-Marjaneh R, Sabbaghzadeh R, Shahidsales S, Joudi-Mashhad M, Ghayour-Mobarhan M, Ferns GA, Khazaei M, Avan A. Inhibition of the Wnt\/b-catenin pathway using PNU-74654 reduces tumor growth in in vitro and in vivo models of colorectal cancer. Tissue Cell. 2022;77:101853. https:\/\/doi.org\/10.1016\/j.tice.2022.101853.","journal-title":"Tissue Cell"},{"key":"4052_CR135","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/medicina59091531","volume":"59","author":"T-L Chien","year":"2023","unstructured":"Chien T-L, Wu Y-C, Lee H-L, Sung W-W, Yu C-Y, Chang Y-C, Lin C-C, Wang C-C, Tsai M-C. PNU-74654 induces cell cycle arrest and inhibits EMT progression in pancreatic cancer. Medicina. 2023;59:1531. https:\/\/doi.org\/10.3390\/medicina59091531.","journal-title":"Medicina"},{"key":"4052_CR136","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/0008-5472.CAN-20-1693","volume":"81","author":"V Tagal","year":"2021","unstructured":"Tagal V, Roth MG. Loss of Aurora kinase signaling allows lung cancer cells to adopt endoreplication and form polyploid giant cancer cells that resist antimitotic drugs. Cancer Res. 2021;81:400\u201313. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1693.","journal-title":"Cancer Res"},{"key":"4052_CR137","doi-asserted-by":"publisher","unstructured":"Zhang S, Zhang D, Yang Z, Zhang X. Tumor Budding, micropapillary Pattern, and polyploidy giant cancer cells in colorectal cancer: current status and future prospects. Stem Cells Int. 2016;2016(4810734). https:\/\/doi.org\/10.1155\/2016\/4810734.","DOI":"10.1155\/2016\/4810734"},{"key":"4052_CR138","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1038\/sj.onc.1209754","volume":"25","author":"S Ohashi","year":"2006","unstructured":"Ohashi S, Sakashita G, Ban R, Nagasawa M, Matsuzaki H, Murata Y, Taniguchi H, Shima H, Furukawa K, Urano T. Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies. Oncogene. 2006;25:7691\u2013702. https:\/\/doi.org\/10.1038\/sj.onc.1209754.","journal-title":"Oncogene"},{"key":"4052_CR139","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.18632\/oncotarget.2190","volume":"5","author":"IA Asteriti","year":"2014","unstructured":"Asteriti IA, Cesare ED, Mattia FD, Hilsenstein V, Neumann B, Cundari E, Lavia P, Guarguaglini G. The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy. Oncotarget. 2014;5:6229\u201342. https:\/\/doi.org\/10.18632\/oncotarget.2190.","journal-title":"Oncotarget"},{"key":"4052_CR140","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/0008-5472.CAN-05-3405","volume":"66","author":"M Stallings-Mann","year":"2006","unstructured":"Stallings-Mann M, Jamieson L, Regala RP, Weems C, Murray NR, Fields AP. A novel Small-Molecule inhibitor of protein kinase C\u03b9 blocks transformed growth of Non\u2013Small-Cell lung cancer cells. Cancer Res. 2006;66:1767\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3405.","journal-title":"Cancer Res"},{"key":"4052_CR141","doi-asserted-by":"crossref","unstructured":"Chen S, Zhao Y, Peng H, Liang L, Li Y, Hu X, Wang B, Xu Y. Polarity protein Par3 sensitizes breast cancer to Paclitaxel by promoting Cell Cycle Arrest. 2021; https:\/\/www.researchsquare.com\/article\/rs-819518\/v1.","DOI":"10.21203\/rs.3.rs-819518\/v1"},{"key":"4052_CR142","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.3390\/ijms21176362","volume":"21","author":"A Joly","year":"2020","unstructured":"Joly A, Rousset R. Tissue adaptation to environmental cues by symmetric and asymmetric division modes of intestinal stem cells. IJMS. 2020;21:6362. https:\/\/doi.org\/10.3390\/ijms21176362.","journal-title":"IJMS"},{"key":"4052_CR143","doi-asserted-by":"publisher","unstructured":"Bley N, Hmedat A, M\u00fcller S, Rolnik R, Rausch A, Lederer M, H\u00fcttelmaier S. Musashi-1-A stemness RBP for cancer therapy? Biology (Basel). 2021;10(407). https:\/\/doi.org\/10.3390\/biology10050407.","DOI":"10.3390\/biology10050407"},{"key":"4052_CR144","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s12276-022-00854-5","volume":"54","author":"G Colozza","year":"2022","unstructured":"Colozza G, Park S-Y, Koo B-K. Clone wars: from molecules to cell competition in intestinal stem cell homeostasis and disease. Exp Mol Med. 2022;54:1367\u201378. https:\/\/doi.org\/10.1038\/s12276-022-00854-5.","journal-title":"Exp Mol Med"},{"key":"4052_CR145","doi-asserted-by":"publisher","unstructured":"Gounder M, Ratan R, Alcindor T, Sch\u00f6ffski P, Van Der Graaf WT, Wilky BA, et al. Nirogacestat, a \u03b3-Secretase inhibitor for desmoid tumors. N Engl J Med. 2023;388:898\u2013912. https:\/\/doi.org\/10.1056\/NEJMoa2210140.","DOI":"10.1056\/NEJMoa2210140"},{"key":"4052_CR146","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.7150\/ijbs.87334","volume":"19","author":"C Song","year":"2023","unstructured":"Song C, Zhang J, Xu C, Gao M, Li N, Geng Q. The critical role of \u03b3-secretase and its inhibitors in cancer and cancer therapeutics. Int J Biol Sci. 2023;19:5089\u2013103. https:\/\/doi.org\/10.7150\/ijbs.87334.","journal-title":"Int J Biol Sci"},{"key":"4052_CR147","doi-asserted-by":"publisher","first-page":"67553","DOI":"10.18632\/oncotarget.18738","volume":"8","author":"DB Pfankuchen","year":"2017","unstructured":"Pfankuchen DB, Baltes F, Batool T, Li J-P, Schlesinger M, Bendas G. Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway. Oncotarget. 2017;8:67553\u201366. https:\/\/doi.org\/10.18632\/oncotarget.18738.","journal-title":"Oncotarget"},{"key":"4052_CR148","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X, Dong Z. Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer. 2021;20:15. https:\/\/doi.org\/10.1186\/s12943-020-01305-3.","journal-title":"Mol Cancer"},{"key":"4052_CR149","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41416-024-02649-z","volume":"130","author":"A Rio-Vilari\u00f1o","year":"2024","unstructured":"Rio-Vilari\u00f1o A, Cenigaonandia-Campillo A, Garc\u00eda-Bautista A, Mateos-G\u00f3mez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, Garc\u00eda-Garc\u00eda L, Galeano C, De Miguel I, Serrano-L\u00f3pez J, Ba\u00f1os N, Fern\u00e1ndez-Ace\u00f1ero MJ, Lacal JC, Medico E, Garc\u00eda-Foncillas J, Cebri\u00e1n A. Inhibition of the AURKA\/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. Br J Cancer. 2024;130:1402\u201313. https:\/\/doi.org\/10.1038\/s41416-024-02649-z.","journal-title":"Br J Cancer"},{"key":"4052_CR150","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cancers14051104","volume":"14","author":"S He","year":"2022","unstructured":"He S, Li Q, Huang Q, Cheng J. Targeting protein kinase C for cancer therapy. Cancers (Basel). 2022;14:1104. https:\/\/doi.org\/10.3390\/cancers14051104.","journal-title":"Cancers (Basel)"},{"key":"4052_CR151","doi-asserted-by":"publisher","first-page":"1213715","DOI":"10.3389\/fonc.2023.1213715","volume":"13","author":"KM Khalid","year":"2024","unstructured":"Khalid KM, Ratnayake WS, Apostolatos CA, Acevedo-Duncan M. Dual Inhibition of atypical PKC signaling and PI3K\/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell renal cell carcinoma. Front Oncol. 2024;13:1213715. https:\/\/doi.org\/10.3389\/fonc.2023.1213715.","journal-title":"Front Oncol"},{"key":"4052_CR152","doi-asserted-by":"publisher","first-page":"100283","DOI":"10.1016\/j.ijpx.2024.100283","volume":"8","author":"MA Haque","year":"2024","unstructured":"Haque MA, Shrestha A, Mikelis CM, Mattheolabakis G. Comprehensive analysis of lipid nanoparticle formulation and Preparation for RNA delivery. Int J Pharmaceutics: X. 2024;8:100283. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100283.","journal-title":"Int J Pharmaceutics: X"},{"key":"4052_CR153","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, Cherif H, Uddin S, Steinhoff M, Marincola FM, Dermime S. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer. 2023;22:20. https:\/\/doi.org\/10.1186\/s12943-023-01723-z.","journal-title":"Mol Cancer"},{"key":"4052_CR154","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-022-01696-5","volume":"22","author":"Z Liu","year":"2023","unstructured":"Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab MAS, Guo W, Huang J, Wang Z, Kesharwani P. Unravelling the enigma of SiRNA and aptamer mediated therapies against pancreatic cancer. Mol Cancer. 2023;22:8. https:\/\/doi.org\/10.1186\/s12943-022-01696-5.","journal-title":"Mol Cancer"},{"key":"4052_CR155","doi-asserted-by":"publisher","unstructured":"Hou Y, Zhao Z, Li P, Cao Y, Zhang Y, Guo C, Nie X, Hou J. Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment. Biochimica et biophysica acta (BBA) - Reviews on cancer. 1879, 189186 (2024). https:\/\/doi.org\/10.1016\/j.bbcan.2024.189186","DOI":"10.1016\/j.bbcan.2024.189186"},{"key":"4052_CR156","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","volume":"18","author":"H De Th\u00e9","year":"2018","unstructured":"De Th\u00e9 H. Differentiation therapy revisited. Nat Rev Cancer. 2018;18:117\u201327. https:\/\/doi.org\/10.1038\/nrc.2017.103.","journal-title":"Nat Rev Cancer"},{"key":"4052_CR157","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1083\/jcb.152.6.1183","volume":"152","author":"A Suzuki","year":"2001","unstructured":"Suzuki A, Yamanaka T, Hirose T, Manabe N, Mizuno K, Shimizu M, Akimoto K, Izumi Y, Ohnishi T, Ohno S. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in Establishing Epithelia-Specific junctional structures. J Cell Biol. 2001;152:1183\u201396. https:\/\/doi.org\/10.1083\/jcb.152.6.1183.","journal-title":"J Cell Biol"},{"key":"4052_CR158","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cmet.2018.11.004","volume":"29","author":"M-J Wu","year":"2019","unstructured":"Wu M-J, Chen Y-S, Kim MR, Chang C-C, Gampala S, Zhang Y, Wang Y, Chang C-Y, Yang J-Y, Chang C-J. Epithelial-Mesenchymal transition directs stem cell Polarity via regulation of Mitofusin. Cell Metabol. 2019;29:993\u2013e10026. https:\/\/doi.org\/10.1016\/j.cmet.2018.11.004.","journal-title":"Cell Metabol"},{"key":"4052_CR159","doi-asserted-by":"publisher","unstructured":"Yang D, Jones MG, Naranjo S, Rideout WM, Min KH (Joseph), Ho R, et al. Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution. Cell 2022;185:1905\u20131923.e25. https:\/\/doi.org\/10.1016\/j.cell.2022.04.015.","DOI":"10.1016\/j.cell.2022.04.015"},{"key":"4052_CR160","doi-asserted-by":"publisher","first-page":"eadi6770","DOI":"10.1126\/sciadv.adi6770","volume":"10","author":"H Zhou","year":"2024","unstructured":"Zhou H, Li I, Bramlett CS, Wang B, Hao J, Yen DP, Ando Y, Fraser SE, Lu R, Shen K. Label-free metabolic optical biomarkers track stem cell fate transition in real time. Sci Adv. 2024;10:eadi6770. https:\/\/doi.org\/10.1126\/sciadv.adi6770.","journal-title":"Sci Adv"},{"key":"4052_CR161","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-022-00527-5","volume":"23","author":"D Entenberg","year":"2023","unstructured":"Entenberg D, Oktay MH, Condeelis JS. Intravital imaging to study cancer progression and metastasis. Nat Rev Cancer. 2023;23:25\u201342. https:\/\/doi.org\/10.1038\/s41568-022-00527-5.","journal-title":"Nat Rev Cancer"},{"key":"4052_CR162","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41467-024-45478-7","volume":"15","author":"J Dai","year":"2024","unstructured":"Dai J, Zheng S, Falco MM, Bao J, Eriksson J, Pikkusaari S, Forst\u00e9n S, Jiang J, Wang W, Gao L, Perez-Villatoro F, Dufva O, Saeed K, Wang Y, Amiryousefi A, F\u00e4rkkil\u00e4 A, Mustjoki S, Kauppi L, Tang J, V\u00e4h\u00e4rautio A. Tracing back primed resistance in cancer via sister cells. Nat Commun. 2024;15:1158. https:\/\/doi.org\/10.1038\/s41467-024-45478-7.","journal-title":"Nat Commun"},{"key":"4052_CR163","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1182\/blood.2022016880","volume":"140","author":"A Wehling","year":"2022","unstructured":"Wehling A, Loeffler D, Zhang Y, Kull T, Donato C, Szczerba B, Ortega C, Lee G, Moor M, G\u00f6ttgens A, Aceto B, Schroeder N. Combining single-cell tracking and omics improves blood stem cell fate regulator identification. Blood. 2022;140:1482\u201395. https:\/\/doi.org\/10.1182\/blood.2022016880.","journal-title":"Blood"},{"key":"4052_CR164","doi-asserted-by":"publisher","unstructured":"Jones MG, Sun D, Min KH J., Colgan WN, Tian L, Weir J.A., Chen VZ, Koblan L.W., Yost K.E., Mathey-Andrews N., Russell A.J.C., Stickels R.R., Balderrama K.S., Rideout W.M., Chang H.Y., Jacks T., Chen F., Weissman J.S., Yosef N., Yang D. Spatiotemporal lineage tracing reveals the dynamic Spatial architecture of tumor growth and metastasis. BioRxiv. 2024;20241021619529. https:\/\/doi.org\/10.1101\/2024.10.21.619529.","DOI":"10.1101\/2024.10.21.619529"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04052-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04052-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:17:23Z","timestamp":1765189043000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-04052-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":164,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4052"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04052-x","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}